SCHEMBL15436159

SCHEMBL15436159

CC1CNc2ncc(Br)cc2OC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20797488 0.78 PDE10A (0.35)
SCHEMBL30524891 0.75 GRM5 (0.36) GRM5
SCHEMBL13352184 0.74 NNMT (0.32) GRM5
SCHEMBL13352183 0.74 NNMT (0.32) GRM5
SCHEMBL14305624 0.74 AKR1B1 (0.38)
SCHEMBL858890 0.72 GRM5 (0.54) GRM5
SCHEMBL2837929 0.70 GRM5 (0.44) GRM5
SCHEMBL2839578 0.70 ALK (0.31) GRM5
SCHEMBL13199674 0.69 HTR2A (0.39)
SCHEMBL31034411 0.69 AKR1B1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2687533-A2 Acrylamide derivatives as FAB I inhibitors Affinium Pharmaceuticals, Inc. (CA) 2014-01-22 EP disclosed